BGM Group Ltd has acquired AIX Inc.'s intelligent platform for approximately $140 million, marking its entry into artificial intelligence and financial services.
BGM Group Ltd has acquired AIX Inc.'s intelligent platform for approximately $140 million, including its subsidiaries RONS Intelligent Technology and Shenzhen Xinbao Investment Management. The acquisition is expected to be completed by the end of 2024.
BGM's CEO, Xin Chen, expressed optimism about the collaboration, highlighting the importance of integrating AIX's technology and expertise for BGM's transformation in the pharmaceutical and healthcare sectors. The partnership aims to enhance BGM's technological capabilities and deliver more efficient solutions to a digital-driven global market.
AIX Inc. has demonstrated potential in the insurance sector with its intelligent platform. The partnership with BGM is expected to extend its reach and align with national policies promoting elderly care and the silver economy.
RONS Technology, a subsidiary of AIX, specializes in digital solutions for the financial and insurance industries. The acquisition enhances BGM's competitive edge in medical and insurance technology, positioning it to offer comprehensive healthcare and insurance solutions.
The integration of resources from intelligent technology and biopharmaceuticals is expected to create a new landscape for healthcare, medicine, and insurance on a global scale.
BGM's presence in the healthcare sector and global pharmaceutical market provides additional application scenarios for the products and services offered by RONS Technology and Xinbao Investment. Xinbao Investment's online and offline insurance trading and service platform, "Baowang," offers risk protection solutions.
By leveraging BGM's international market network and pharmaceutical expertise, both RONS Technology and Xinbao Investment aim to explore novel development models in the healthcare and insurance industries.
The collaboration between BGM and AIX represents a strategic alignment of visions for the future of healthcare and insurance. The integration of AIX's intelligent platform with BGM's pharmaceutical expertise is expected to yield innovative solutions that address the evolving needs of consumers and businesses.
This partnership is set to redefine service delivery standards in the healthcare and insurance sectors as the demand for intelligent solutions continues to rise. The anticipated synergies from this acquisition will enhance operational efficiencies and create a robust framework for addressing the complexities of modern healthcare and insurance needs.